This data is in accord with Yee et al. who found in a large cohort including 10996 T2DM patients, new users of oral antidiabetic agents, that use of statins was associated with a delay in starting insulin treatment [30]. The gene discussed is INS; the disease is type 2 diabetes mellitus.